These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16197723)

  • 1. Vaccine therapies for pediatric malignancies.
    Rousseau RF; Brenner MK
    Cancer J; 2005; 11(4):331-9. PubMed ID: 16197723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor vaccines--application to childhood cancer.
    Roskrow MA; Zibert A; Souquet M; Dilloo D
    Klin Padiatr; 1999; 211(4):336-46. PubMed ID: 10472573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
    Ohashi K; Kobayashi G; Fang S; Zhu X; Antonia SJ; Krieg AM; Sandler AD
    J Pediatr Surg; 2006 Aug; 41(8):1361-8. PubMed ID: 16863838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell vaccines in acute leukaemia.
    Duncan C; Roddie H
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):521-41. PubMed ID: 18790453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide vaccine therapy for leukemia.
    Rezvani K
    Int J Hematol; 2011 Mar; 93(3):274-280. PubMed ID: 21380929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma and dendritic cell function.
    Redlinger RE; Mailliard RB; Barksdale EM
    Semin Pediatr Surg; 2004 Feb; 13(1):61-71. PubMed ID: 14765372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts.
    Mohty M; Olive D; Gaugler B
    Leukemia; 2002 Nov; 16(11):2197-204. PubMed ID: 12399962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell vaccine against leukemia: advances and perspectives.
    Tesfatsion DA
    Immunotherapy; 2014; 6(4):485-96. PubMed ID: 24815786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodiagnosis and immunotherapy of childhood malignancies.
    Bernstein I; Kersey J; Seeger R; Andrews R
    Pediatr Clin North Am; 1985 Jun; 32(3):575-99. PubMed ID: 3889799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(4):2665-76. PubMed ID: 10953341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma.
    Miles SA; Sandler AD
    Adv Drug Deliv Rev; 2009 Mar; 61(3):275-82. PubMed ID: 19186194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation dendritic cell-based vaccines for leukemia patients.
    Hoffmann JM; Schmitt M; Ni M; Schmitt A
    Immunotherapy; 2017 Jan; 9(2):173-181. PubMed ID: 28128712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia vaccines.
    Kochenderfer JN; Molldrem JJ
    Curr Oncol Rep; 2001 May; 3(3):193-200. PubMed ID: 11296128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
    Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
    Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin.
    Russell HV; Strother D; Mei Z; Rill D; Popek E; Biagi E; Yvon E; Brenner M; Rousseau R
    J Immunother; 2007; 30(2):227-33. PubMed ID: 17471169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.
    Oka Y; Tsuboi A; Fujiki F; Li Z; Nakajima H; Hosen N; Shirakata T; Nishida S; Oji Y; Kawase I; Sugiyama H
    Anticancer Agents Med Chem; 2009 Sep; 9(7):787-97. PubMed ID: 19538172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines in leukemia.
    Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
    Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
    [No Abstract]   [Full Text] [Related]  

  • 20. Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells.
    Bao H; Wu D
    Curr Stem Cell Res Ther; 2017; 12(3):188-196. PubMed ID: 28025936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.